FDA Archives - Page 3 of 28 - Renal and Urology News

FDA

Enlarged Prostate

Expanded Indications Approved for UroLift

FDA has approved new indicationsfor the UroLift System (NeoTract),a treatment for benign prostatichyperplasia that involves placement,via a minimally invasive procedure, ofpermanent implants that relieve prostaticobstruction and open the urethra.  UroLift is now approved for use inmen with an obstructive median lobeand men as young as 45 years. Previously,UroLift was contraindicated inpatients with an obstructive medianlobe…

Next post in Diabetes